首页> 外文OA文献 >Evaluation of a minimally invasive non-calibrated pulse contour cardiac output monitor (FloTrac/Vigileo) in anaesthetized dogs
【2h】

Evaluation of a minimally invasive non-calibrated pulse contour cardiac output monitor (FloTrac/Vigileo) in anaesthetized dogs

机译:对麻醉犬的微创非标定脉搏轮廓心输出量监测仪(FloTrac / Vigileo)的评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective  To evaluate the accuracy of a new cardiac output monitor (FloTrac/Vigileo), originally designed for humans, in dogs. This pulse contour cardiac output monitoring system cannot be calibrated and measures cardiac output (Q̇t) from a standard arterial catheter. Study design  Prospective experimental trial. Animals  Eight adult Beagle dogs weighing 13.1 (9.8-17.1) kg [median (range)]. Methods  Anaesthesia in the dogs was maintained using isoflurane. A pulmonary artery catheter and a metatarsal arterial catheter (22 gauge) were placed. Cardiac output was measured simultaneously 331 times by thermodilution and FloTrac technique. A broad spectrum of Q̇t measurements was achieved through alterations of isoflurane concentration, administration of propofol boluses and dobutamine infusions. Agreement between the methods was quantified with Bland Altman analysis and disagreement was assessed with linear mixed models. Results  Median (10th and 90th percentile) cardiac output as measured with thermodilution was 2.54 (1.47 and 5.15) L minute(-1) and as measured with FloTrac 8.6 (3.9 and 17.3) L minute(-1) . FloTrac measurements were consistently higher with a mean bias of 7 L minute(-1) and limits of agreement of -3.15 to 17.17 L minute(-1) . Difference between the methods was most pronounced in high Q̇t measurements. Linear mixed models showed an estimated difference between the two methods of 8.05 (standard error 1.18) L minute(-1) and a significant interaction between mean arterial pressure and method. Standard deviation (4.45 higher) with the FloTrac method compared to thermodilution was increased. Conclusion  Compared to thermodilution measurements, the FloTrac system was influenced to a higher degree by arterial blood pressure, resulting in consistent overestimation of cardiac output. Clinical Relevance  The FloTrac monitor, whose algorithms were developed based on human data, cannot be used as an alternative for thermodilution in dogs.
机译:目的评价最初为人设计的犬用新型心输出量监测仪(FloTrac / Vigileo)的准确性。此脉冲轮廓心输出量监视系统无法校准,无法测量标准动脉导管的心输出量(Q̇t)。研究设计预期的实验性试验。动物:八只成年比格犬,重13.1(9.8-17.1)公斤[中位数(范围)]。方法:用异氟烷维持麻醉。放置肺动脉导管和meta动脉导管(22英寸规格)。通过热稀释和FloTrac技术同时测量331次心脏输出量。通过改变异氟烷浓度,异丙酚大剂量给药和多巴酚丁胺输注可以实现广泛的Q̇t测量。方法之间的一致性通过Bland Altman分析进行量化,分歧通过线性混合模型进行评估。结果:热稀释法测得的中位数(第10和第90个百分位数)心输出量为2.54(1.47和5.15)L·分钟(-1),FloTrac 8.6(3.9和17.3)L·分钟(-1)。 FloTrac测量值始终较高,平均偏差为7 L minute(-1),一致性极限为-3.15至17.17 L minute(-1)。在高Qtt测量中,方法之间的差异最为明显。线性混合模型显示两种方法之间的估计差异为8.05(标准误差1.18)L methodsminute(-1),并且平均动脉压和方法之间存在显着的相互作用。与热稀释法相比,FloTrac方法的标准偏差增加了4.45倍。结论与热稀释法测量相比,FloTrac系统受到动脉血压的影响更大,导致对心输出量的持续高估。临床相关性FloTrac监测器的算法是根据人类数据开发的,不能用作犬热稀释的替代方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号